| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Calcitonin | 15 | 2019 | 201 | 6.72 | Why? |
| Protein Precursors | 9 | 2021 | 425 | 2.80 | Why? |
| Anti-Bacterial Agents | 25 | 2019 | 10083 | 2.72 | Why? |
| Refeeding Syndrome | 3 | 2017 | 7 | 2.12 | Why? |
| Graves Disease | 3 | 2019 | 61 | 1.96 | Why? |
| Sepsis | 10 | 2019 | 3517 | 1.74 | Why? |
| Community-Acquired Infections | 13 | 2021 | 2328 | 1.74 | Why? |
| Respiratory Tract Infections | 12 | 2018 | 6817 | 1.70 | Why? |
| Biomarkers | 36 | 2021 | 23361 | 1.61 | Why? |
| Bacterial Infections | 8 | 2019 | 2229 | 1.53 | Why? |
| Adrenomedullin | 4 | 2021 | 217 | 1.45 | Why? |
| Methylamines | 2 | 2017 | 23 | 1.36 | Why? |
| Antimicrobial Stewardship | 4 | 2019 | 931 | 1.34 | Why? |
| Pneumonia | 13 | 2021 | 5652 | 1.31 | Why? |
| Switzerland | 17 | 2021 | 2738 | 1.25 | Why? |
| Serotonin | 2 | 2017 | 137 | 1.25 | Why? |
| Tryptophan | 2 | 2017 | 218 | 1.18 | Why? |
| Malnutrition | 4 | 2019 | 932 | 1.16 | Why? |
| Arginine | 2 | 2017 | 377 | 1.09 | Why? |
| Enteral Nutrition | 2 | 2018 | 320 | 1.08 | Why? |
| Metabolomics | 3 | 2019 | 921 | 1.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 5 | 2019 | 3832 | 1.02 | Why? |
| Nutritional Support | 2 | 2019 | 447 | 1.01 | Why? |
| Nutritional Status | 3 | 2018 | 1403 | 0.96 | Why? |
| Hyperthyroidism | 2 | 2019 | 63 | 0.92 | Why? |
| Endothelin-1 | 1 | 2021 | 69 | 0.89 | Why? |
| Deficiency Diseases | 1 | 2021 | 66 | 0.87 | Why? |
| Peptide Fragments | 3 | 2021 | 2075 | 0.84 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2017 | 76 | 0.82 | Why? |
| Renin | 1 | 2021 | 167 | 0.82 | Why? |
| Receptors, Thyrotropin | 1 | 2019 | 8 | 0.81 | Why? |
| Antithyroid Agents | 1 | 2019 | 28 | 0.79 | Why? |
| Kynurenine | 2 | 2017 | 140 | 0.77 | Why? |
| Angiotensin I | 1 | 2021 | 200 | 0.76 | Why? |
| Tyrosine | 1 | 2018 | 66 | 0.74 | Why? |
| Tryptophan Hydroxylase | 1 | 2017 | 7 | 0.71 | Why? |
| Bone Diseases | 1 | 2019 | 101 | 0.70 | Why? |
| Trace Elements | 1 | 2021 | 284 | 0.68 | Why? |
| Natriuretic Peptides | 1 | 2017 | 66 | 0.66 | Why? |
| Parenteral Nutrition | 1 | 2018 | 184 | 0.63 | Why? |
| Erythrocyte Indices | 1 | 2018 | 207 | 0.63 | Why? |
| Nutrition Assessment | 2 | 2017 | 527 | 0.62 | Why? |
| Proportional Hazards Models | 10 | 2019 | 6543 | 0.61 | Why? |
| Transplantation, Homologous | 1 | 2019 | 757 | 0.61 | Why? |
| Prognosis | 21 | 2021 | 32490 | 0.59 | Why? |
| Angiotensin II | 1 | 2021 | 601 | 0.57 | Why? |
| Calcitonin Gene-Related Peptide | 4 | 2019 | 52 | 0.57 | Why? |
| Patient Outcome Assessment | 2 | 2018 | 707 | 0.56 | Why? |
| Thyroid Diseases | 1 | 2019 | 285 | 0.56 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.55 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.55 | Why? |
| Mortality | 6 | 2018 | 7132 | 0.54 | Why? |
| Thyroid Neoplasms | 1 | 2019 | 422 | 0.53 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.51 | Why? |
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 2426 | 0.51 | Why? |
| Prospective Studies | 25 | 2021 | 43301 | 0.46 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.46 | Why? |
| Acute Disease | 7 | 2019 | 6029 | 0.44 | Why? |
| Dietary Supplements | 2 | 2021 | 2251 | 0.44 | Why? |
| Diagnosis-Related Groups | 1 | 2011 | 167 | 0.42 | Why? |
| Hydrocortisone | 3 | 2017 | 1790 | 0.42 | Why? |
| Fee-for-Service Plans | 1 | 2011 | 144 | 0.42 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.42 | Why? |
| Middle Aged | 53 | 2021 | 270681 | 0.42 | Why? |
| Humans | 90 | 2021 | 930598 | 0.42 | Why? |
| Patient-Centered Care | 1 | 2019 | 860 | 0.42 | Why? |
| Aged | 46 | 2021 | 215776 | 0.42 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.40 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.40 | Why? |
| Length of Stay | 11 | 2019 | 11042 | 0.40 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.39 | Why? |
| Patient Admission | 4 | 2018 | 5250 | 0.38 | Why? |
| Male | 55 | 2021 | 367725 | 0.37 | Why? |
| Randomized Controlled Trials as Topic | 8 | 2019 | 10649 | 0.36 | Why? |
| Aged, 80 and over | 26 | 2021 | 88759 | 0.36 | Why? |
| Female | 53 | 2021 | 380317 | 0.36 | Why? |
| Kaplan-Meier Estimate | 5 | 2018 | 4260 | 0.36 | Why? |
| Diet | 2 | 2018 | 2052 | 0.36 | Why? |
| Bacteremia | 1 | 2019 | 1372 | 0.36 | Why? |
| Evidence-Based Medicine | 1 | 2021 | 3228 | 0.35 | Why? |
| Autoantibodies | 1 | 2019 | 2094 | 0.34 | Why? |
| Multivariate Analysis | 6 | 2018 | 5440 | 0.34 | Why? |
| Legionnaires' Disease | 1 | 2009 | 108 | 0.34 | Why? |
| Adrenocorticotropic Hormone | 2 | 2017 | 107 | 0.34 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.34 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.33 | Why? |
| Algorithms | 4 | 2019 | 7346 | 0.33 | Why? |
| Prednisone | 3 | 2021 | 652 | 0.32 | Why? |
| Tandem Mass Spectrometry | 3 | 2017 | 1031 | 0.32 | Why? |
| Emergency Service, Hospital | 12 | 2020 | 14232 | 0.31 | Why? |
| Metabolic Networks and Pathways | 2 | 2018 | 285 | 0.31 | Why? |
| Cohort Studies | 11 | 2021 | 36005 | 0.31 | Why? |
| Area Under Curve | 6 | 2021 | 2564 | 0.31 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.30 | Why? |
| Survival Analysis | 5 | 2021 | 7592 | 0.30 | Why? |
| Glycopeptides | 2 | 2018 | 199 | 0.29 | Why? |
| APACHE | 2 | 2018 | 682 | 0.29 | Why? |
| Intensive Care Units | 9 | 2021 | 29594 | 0.29 | Why? |
| Risk Factors | 12 | 2021 | 71621 | 0.28 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.26 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2019 | 5993 | 0.25 | Why? |
| Chromatography, Liquid | 2 | 2017 | 640 | 0.25 | Why? |
| Recurrence | 4 | 2019 | 3675 | 0.25 | Why? |
| ROC Curve | 6 | 2021 | 6024 | 0.24 | Why? |
| C-Reactive Protein | 6 | 2021 | 7972 | 0.24 | Why? |
| Quality of Health Care | 3 | 2019 | 1948 | 0.23 | Why? |
| Critical Illness | 4 | 2019 | 17281 | 0.23 | Why? |
| Ascorbic Acid Deficiency | 1 | 2021 | 16 | 0.23 | Why? |
| Simplified Acute Physiology Score | 2 | 2018 | 102 | 0.23 | Why? |
| Hospital Mortality | 7 | 2021 | 22087 | 0.22 | Why? |
| Adrenal Cortex Hormones | 2 | 2019 | 6537 | 0.22 | Why? |
| Triage | 2 | 2017 | 7151 | 0.22 | Why? |
| Adult | 24 | 2021 | 244371 | 0.22 | Why? |
| Magnesium Deficiency | 1 | 2021 | 28 | 0.22 | Why? |
| Treatment Failure | 2 | 2017 | 2106 | 0.22 | Why? |
| Vitamin B 12 Deficiency | 1 | 2021 | 57 | 0.21 | Why? |
| Critical Care | 3 | 2019 | 14081 | 0.21 | Why? |
| Emergency Medical Services | 1 | 2017 | 3557 | 0.21 | Why? |
| Time Factors | 7 | 2018 | 31397 | 0.21 | Why? |
| Pulmonary Embolism | 1 | 2019 | 4775 | 0.20 | Why? |
| Metabolic Syndrome | 2 | 2018 | 810 | 0.20 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2021 | 9659 | 0.20 | Why? |
| Dihydrotestosterone | 1 | 2018 | 39 | 0.19 | Why? |
| Risk Assessment | 9 | 2019 | 25439 | 0.19 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 2 | 2018 | 1165 | 0.19 | Why? |
| Predictive Value of Tests | 6 | 2018 | 9537 | 0.19 | Why? |
| Endpoint Determination | 1 | 2021 | 344 | 0.19 | Why? |
| Discriminant Analysis | 1 | 2019 | 170 | 0.19 | Why? |
| Iodine Radioisotopes | 1 | 2019 | 124 | 0.19 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.19 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.19 | Why? |
| Food, Formulated | 1 | 2018 | 10 | 0.19 | Why? |
| Cause of Death | 3 | 2017 | 4823 | 0.19 | Why? |
| Inpatients | 4 | 2018 | 5161 | 0.18 | Why? |
| Multiple Chronic Conditions | 1 | 2019 | 115 | 0.18 | Why? |
| Least-Squares Analysis | 1 | 2019 | 254 | 0.18 | Why? |
| Logistic Models | 4 | 2021 | 9089 | 0.18 | Why? |
| Drug Misuse | 1 | 2018 | 42 | 0.18 | Why? |
| Polydipsia | 1 | 2017 | 2 | 0.18 | Why? |
| Patient Satisfaction | 1 | 2011 | 2517 | 0.18 | Why? |
| Semicircular Canals | 1 | 2017 | 2 | 0.18 | Why? |
| Fibroblast Growth Factors | 1 | 2019 | 119 | 0.18 | Why? |
| Out-of-Hospital Cardiac Arrest | 2 | 2018 | 1047 | 0.18 | Why? |
| Chromatography, Affinity | 1 | 2020 | 310 | 0.18 | Why? |
| Cosyntropin | 1 | 2017 | 9 | 0.18 | Why? |
| Hominidae | 1 | 2017 | 23 | 0.17 | Why? |
| Insulin-Like Growth Factor I | 1 | 2018 | 119 | 0.17 | Why? |
| Glucocorticoids | 4 | 2021 | 4431 | 0.17 | Why? |
| Follow-Up Studies | 5 | 2019 | 17020 | 0.17 | Why? |
| Acromegaly | 1 | 2018 | 79 | 0.17 | Why? |
| Adrenergic beta-Antagonists | 1 | 2021 | 465 | 0.17 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.17 | Why? |
| Hypogonadism | 1 | 2018 | 196 | 0.17 | Why? |
| Micronutrients | 1 | 2021 | 310 | 0.17 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2017 | 1261 | 0.16 | Why? |
| Pilot Projects | 2 | 2019 | 5182 | 0.16 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.16 | Why? |
| Pituitary Neoplasms | 1 | 2018 | 130 | 0.16 | Why? |
| Energy Intake | 1 | 2019 | 323 | 0.16 | Why? |
| Pneumonia, Mycoplasma | 1 | 2019 | 292 | 0.16 | Why? |
| Comorbidity | 6 | 2021 | 34796 | 0.16 | Why? |
| Disease Progression | 4 | 2020 | 13580 | 0.16 | Why? |
| Causality | 1 | 2020 | 857 | 0.16 | Why? |
| Locomotion | 1 | 2017 | 130 | 0.15 | Why? |
| Biological Assay | 1 | 2019 | 367 | 0.15 | Why? |
| Transitional Care | 1 | 2017 | 135 | 0.15 | Why? |
| Adenoma | 1 | 2018 | 215 | 0.15 | Why? |
| Water-Electrolyte Imbalance | 1 | 2016 | 119 | 0.15 | Why? |
| Transplantation, Autologous | 1 | 2016 | 364 | 0.15 | Why? |
| Hospitalization | 9 | 2021 | 54280 | 0.15 | Why? |
| Leukocytosis | 1 | 2017 | 280 | 0.14 | Why? |
| Nutrition Policy | 1 | 2016 | 132 | 0.14 | Why? |
| Organ Dysfunction Scores | 2 | 2019 | 1475 | 0.14 | Why? |
| Evaluation Studies as Topic | 1 | 2016 | 391 | 0.14 | Why? |
| Benchmarking | 1 | 2019 | 627 | 0.14 | Why? |
| Interleukin-1 | 1 | 2018 | 438 | 0.14 | Why? |
| Creatinine | 1 | 2021 | 1443 | 0.14 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.14 | Why? |
| Neutropenia | 1 | 2018 | 388 | 0.14 | Why? |
| Leukocyte Count | 2 | 2021 | 3178 | 0.13 | Why? |
| Severity of Illness Index | 5 | 2019 | 48226 | 0.13 | Why? |
| Consensus | 2 | 2019 | 6345 | 0.13 | Why? |
| Zinc | 1 | 2021 | 817 | 0.13 | Why? |
| Treatment Outcome | 9 | 2021 | 51732 | 0.13 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.13 | Why? |
| Subacute Care | 1 | 2018 | 315 | 0.13 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.13 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.12 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.12 | Why? |
| Early Diagnosis | 2 | 2019 | 2443 | 0.12 | Why? |
| Hyponatremia | 1 | 2017 | 371 | 0.12 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.12 | Why? |
| Testosterone | 1 | 2018 | 596 | 0.12 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.12 | Why? |
| Blood Pressure | 2 | 2021 | 2198 | 0.12 | Why? |
| Sodium | 2 | 2017 | 309 | 0.12 | Why? |
| Statistics, Nonparametric | 3 | 2021 | 1008 | 0.11 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Longitudinal Studies | 2 | 2017 | 9893 | 0.11 | Why? |
| Shock | 1 | 2018 | 1868 | 0.11 | Why? |
| Sex Characteristics | 1 | 2018 | 1120 | 0.10 | Why? |
| Anemia | 1 | 2018 | 789 | 0.10 | Why? |
| Nervous System Diseases | 3 | 2018 | 4092 | 0.10 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.10 | Why? |
| Quality of Life | 1 | 2011 | 9820 | 0.10 | Why? |
| Metformin | 1 | 2017 | 640 | 0.10 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.10 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.10 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.09 | Why? |
| Meta-Analysis as Topic | 1 | 2016 | 1289 | 0.09 | Why? |
| Extracellular Traps | 1 | 2018 | 1036 | 0.09 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.09 | Why? |
| Diabetes Mellitus | 1 | 2011 | 8207 | 0.09 | Why? |
| Observational Studies as Topic | 1 | 2016 | 1887 | 0.09 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.09 | Why? |
| Cerebrovascular Disorders | 1 | 2016 | 1040 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.09 | Why? |
| Legionella pneumophila | 1 | 2009 | 143 | 0.09 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.08 | Why? |
| Family | 1 | 2021 | 2909 | 0.08 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Survivors | 1 | 2019 | 2619 | 0.08 | Why? |
| Patient Compliance | 1 | 2016 | 1468 | 0.08 | Why? |
| Headache | 1 | 2017 | 2257 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.07 | Why? |
| Head and Neck Neoplasms | 1 | 2018 | 1568 | 0.07 | Why? |
| Neutrophils | 2 | 2019 | 5476 | 0.07 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.07 | Why? |
| Patient Readmission | 3 | 2019 | 1543 | 0.07 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.07 | Why? |
| Practice Guidelines as Topic | 2 | 2019 | 15421 | 0.07 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.06 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.06 | Why? |
| Body Temperature | 1 | 2009 | 875 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2018 | 3419 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Platelet Count | 1 | 2009 | 1381 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Antirheumatic Agents | 1 | 2017 | 3023 | 0.06 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2016 | 2654 | 0.06 | Why? |
| Cardiovascular Diseases | 2 | 2017 | 11497 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2019 | 7330 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2016 | 2580 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2016 | 2570 | 0.06 | Why? |
| Registries | 2 | 2018 | 12327 | 0.05 | Why? |
| Databases, Factual | 1 | 2016 | 6248 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| L-Lactate Dehydrogenase | 1 | 2009 | 1995 | 0.05 | Why? |
| Biomarkers, Pharmacological | 1 | 2021 | 150 | 0.05 | Why? |
| Sputum | 1 | 2009 | 1720 | 0.05 | Why? |
| Hyperglycemia | 1 | 2011 | 1363 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.05 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.05 | Why? |
| United States | 2 | 2017 | 46150 | 0.05 | Why? |
| Fever | 1 | 2016 | 7795 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Patient Discharge | 3 | 2021 | 5696 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Validation Studies as Topic | 1 | 2019 | 121 | 0.05 | Why? |
| Adaptive Immunity | 1 | 2011 | 2585 | 0.05 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.05 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.05 | Why? |
| Comparative Effectiveness Research | 1 | 2019 | 178 | 0.05 | Why? |
| Polydipsia, Psychogenic | 1 | 2017 | 2 | 0.05 | Why? |
| Holistic Health | 1 | 2019 | 90 | 0.05 | Why? |
| Pituitary Gland | 1 | 2018 | 65 | 0.04 | Why? |
| Regression Analysis | 2 | 2017 | 2484 | 0.04 | Why? |
| Cortodoxone | 1 | 2017 | 2 | 0.04 | Why? |
| Corticosterone | 1 | 2017 | 18 | 0.04 | Why? |
| Analysis of Variance | 1 | 2021 | 950 | 0.04 | Why? |
| Mycoplasma pneumoniae | 1 | 2019 | 233 | 0.04 | Why? |
| Follicle Stimulating Hormone | 1 | 2017 | 73 | 0.04 | Why? |
| Luteinizing Hormone | 1 | 2017 | 91 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2018 | 249 | 0.04 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2019 | 350 | 0.04 | Why? |
| Prolactin | 1 | 2017 | 68 | 0.04 | Why? |
| Biometry | 1 | 2017 | 69 | 0.04 | Why? |
| Resource Allocation | 2 | 2019 | 1771 | 0.04 | Why? |
| Hypernatremia | 1 | 2018 | 182 | 0.04 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Lactic Acid | 1 | 2019 | 393 | 0.04 | Why? |
| Human Growth Hormone | 1 | 2017 | 120 | 0.04 | Why? |
| Thyrotropin | 1 | 2017 | 262 | 0.04 | Why? |
| International Agencies | 1 | 2016 | 202 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2019 | 657 | 0.03 | Why? |
| Delivery of Health Care | 2 | 2019 | 15909 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2019 | 827 | 0.03 | Why? |
| Adolescent | 3 | 2019 | 86841 | 0.03 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.03 | Why? |
| Prednisolone | 1 | 2017 | 443 | 0.03 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.03 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.03 | Why? |
| Drug Monitoring | 1 | 2021 | 1408 | 0.03 | Why? |
| Immunity, Innate | 1 | 2011 | 6570 | 0.03 | Why? |
| Multimorbidity | 1 | 2017 | 703 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.03 | Why? |
| Patient Transfer | 1 | 2019 | 898 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.03 | Why? |
| Sweden | 1 | 2019 | 1969 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2019 | 1013 | 0.03 | Why? |
| Animals | 2 | 2017 | 78931 | 0.03 | Why? |
| Cytokines | 1 | 2011 | 15010 | 0.02 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.02 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.02 | Why? |
| Neoplasms | 1 | 2016 | 17251 | 0.02 | Why? |
| Stress, Psychological | 2 | 2021 | 10231 | 0.02 | Why? |
| Delivery of Health Care, Integrated | 1 | 2019 | 1549 | 0.02 | Why? |
| England | 1 | 2019 | 5116 | 0.02 | Why? |
| Lymphocytes | 1 | 2019 | 3056 | 0.02 | Why? |
| Resilience, Psychological | 1 | 2021 | 2329 | 0.02 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.02 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2018 | 1876 | 0.02 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| France | 1 | 2019 | 12074 | 0.01 | Why? |
| Saliva | 1 | 2017 | 4679 | 0.01 | Why? |
| Spain | 1 | 2019 | 15545 | 0.01 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.01 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Italy | 1 | 2019 | 38444 | 0.01 | Why? |